DK189982A - Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler - Google Patents

Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler Download PDF

Info

Publication number
DK189982A
DK189982A DK189982A DK189982A DK189982A DK 189982 A DK189982 A DK 189982A DK 189982 A DK189982 A DK 189982A DK 189982 A DK189982 A DK 189982A DK 189982 A DK189982 A DK 189982A
Authority
DK
Denmark
Prior art keywords
octasaccharides
abreviation
preparation
see diagramm
denoted below
Prior art date
Application number
DK189982A
Other languages
Danish (da)
English (en)
Inventor
J C Lormeau
J Choay
M Petitou
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Publication of DK189982A publication Critical patent/DK189982A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/02Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02007Heparin lyase (4.2.2.7), i.e. heparinase I

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK189982A 1981-04-29 1982-04-28 Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler DK189982A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8108604A FR2504928A1 (fr) 1981-04-29 1981-04-29 Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments

Publications (1)

Publication Number Publication Date
DK189982A true DK189982A (da) 1982-10-30

Family

ID=9257922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK189982A DK189982A (da) 1981-04-29 1982-04-28 Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler

Country Status (9)

Country Link
EP (1) EP0064452B1 (de)
JP (1) JPS57190001A (de)
AT (1) ATE12791T1 (de)
CA (1) CA1180292A (de)
DE (1) DE3263083D1 (de)
DK (1) DK189982A (de)
ES (1) ES511470A0 (de)
FR (1) FR2504928A1 (de)
IE (1) IE52906B1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP0209924A1 (de) * 1985-07-12 1987-01-28 Akzo N.V. Antithrombotikum auf Basis von Glykosaminoglykan, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung
US5106734A (en) * 1986-04-30 1992-04-21 Novo Nordisk A/S Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
EP0861903A1 (de) * 1997-02-22 1998-09-02 Lansing, Manfred Verfahren zum reversiblen Immobilisieren von Oligo- oder Polysacchariden
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP1582531A1 (de) 2004-03-24 2005-10-05 Aventis Pharma S.A. Verfahren zur Oxydierung nicht-fraktionierten Heparins und die Detektion der Anwesenheit oder Abwesenheit von Glykoserin in Heparin und in von Heparin abgeleiteten Produkten
EP1792621B1 (de) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Oral verabreichbare Heparinderivate
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
EP3398971A4 (de) * 2015-12-30 2019-09-25 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Sulfatiertes heparinoligosaccharid und herstellungsverfahren und anwendung davon
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
JP2022540849A (ja) 2019-07-09 2022-09-20 オプティムヴィア、エルエルシー 抗凝固性多糖類の合成方法
JP7611465B2 (ja) * 2019-10-10 2025-01-10 ジェイ・アイ・サイエンス有限会社 溶離液性の利用フラクションコレクター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
JPH0231721A (ja) * 1988-07-20 1990-02-01 Matsushita Electric Ind Co Ltd 充電式掃除機

Also Published As

Publication number Publication date
EP0064452A1 (de) 1982-11-10
ES8302094A1 (es) 1983-02-01
EP0064452B1 (de) 1985-04-17
CA1180292A (en) 1985-01-02
IE820741L (en) 1982-10-29
ES511470A0 (es) 1983-02-01
DE3263083D1 (en) 1985-05-23
FR2504928B1 (de) 1984-02-24
ATE12791T1 (de) 1985-05-15
JPS57190001A (en) 1982-11-22
IE52906B1 (en) 1988-04-13
FR2504928A1 (fr) 1982-11-05

Similar Documents

Publication Publication Date Title
DK189982A (da) Oligosaccharider med korte kaeder der har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler
AU627207B2 (en) Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent
ES2174064T3 (es) Derivados de 1,3 - dihidro - 1 - (fenilalquil) - 2h - imidazol - 2 - ona que presentan una actividad frente a pde iv y a citoquinas.
ES312813A1 (es) Procedimiento para la produccion de nuevos derivados de imidazol (2, 1, b) tiazol
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
ES2007411A6 (es) Procedimiento de preparar nuevos agentes psicoestimulantes.
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
BR0008778A (pt) Análogos de prostaglandinas seletivos para fpc16 insaturados
BR0008776A (pt) Análogos de prostaglandinas fp-seletivosinsaturados c16
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ZA865735B (en) Pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
BR0109328A (pt) Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
ES2149403T3 (es) Benciloxicarbonilguanidinas sustituidas como inhibidores del intercambiador de protones de sodio, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
NO20011091L (no) Umettede hydroksiminsyrederivater som PARP inhibitorer
BR9912581A (pt) Processos para tratar ou prevenir um distúrbio causado por disfunção da motilidade gastrointestinal em um humano e para elicitar um efeito procinético em um humano, e, composição farmacêutica
BR0109617A (pt) Composição farmacêutica, oligossacarìdeo, processo de preparação de oligossacarìdeos, e, utilização de oligossacarìdeos
BR9909268A (pt) C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fp
ATE7202T1 (de) Nichtadsorbierbare, mukolytische verbindungen, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die diese verbindungen als wirkstoff enthalten.
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
JPH06248267A (ja) 新規抗酸化剤
Moosa Peripheral neuropathy in Leigh's encephalomyelopathy
AR005724A1 (es) Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple
DK291786D0 (da) Neuroleptisk aktivt, farmaceutisk praeparat og fremgangsmaade til dets fremstilling
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment